RESUMEN
Timely diagnosis of impending graft rejection is crucial for effective therapeutic intervention after allogeneic hematopoietic stem cell transplantation (SCT). We have investigated the predictive potential of early leukocyte subset-specific chimerism for graft loss in children undergoing SCT. In total, 192 pediatric patients transplanted for the treatment of malignant and non-malignant diseases after reduced-intensity or myeloablative conditioning were investigated. Surveillance of lineage-specific chimerism was initiated upon first appearance of leukocyte counts amenable to cell sorting. Graft rejection occurred in 23 patients between 24 and 492 days post-transplant (median 63 days). The first chimerism analysis of T and NK cells performed at a median of 20 days after SCT identified three different risk groups that were independent from the conditioning regimen: recipient chimerism (RC) levels in T cells below 50% indicated a very low risk of rejection (1.4%), whereas high levels of RC (>90%) both in T and NK cells heralded graft loss in the majority of patients (90%) despite therapeutic interventions. RC >50% in T cells and ≤90% in NK cells defined an intermediate-risk group in which timely immunotherapy frequently prevented rejection. Early assessment of T- and NK-cell chimerism can therefore be instrumental in the risk assessment and therapeutic management of imminent graft rejection.
Asunto(s)
Linaje de la Célula , Quimerismo , Rechazo de Injerto/diagnóstico , Trasplante de Células Madre Hematopoyéticas , Células Asesinas Naturales/metabolismo , Linfocitos T/metabolismo , Adolescente , Adulto , Niño , Preescolar , Rechazo de Injerto/metabolismo , Humanos , Inmunofenotipificación , Lactante , Depleción Linfocítica , Células Mieloides/metabolismo , Pronóstico , Medición de Riesgo , Acondicionamiento Pretrasplante , Trasplante Homólogo , Adulto JovenRESUMEN
Chimaerism of FACS-sorted leucocyte subsets (CD14+, CD15+, CD3-/56+, CD3+/4+, CD3+/8+, CD19+) was monitored prospectively between days +14 and +100 in 39 children undergoing allogeneic stem cell transplantation with reduced intensity-conditioning regimens. Cell subsets exceeding 1% of nucleated cells were subject to cell sorting. Chimaerism was analysed by dual-colour FISH and/or by short tandem repeat-polymerase chain reaction. The chimaerism pattern on day +28 was evaluated with regard to its correlation with graft rejection. Of 39 patients, nine patients had donor chimaerism (DC) in all subsets. Mixed/recipient chimaerism (MC/RC) was detectable within T cells in 62%, within NK cells in 39% and within monocytes and granulocytes in 38% of the patients. The correlation of secondary graft rejection with the chimaerism pattern on day +28 revealed the strongest association between RC in NK-cells (P<0.0001), followed by T cells (P=0.001), and granulocytes and monocytes (P=0.034). Notably, patients with RC in T cells rejected their graft only if MC or RC was also present in the NK-cell subset. By contrast, none of the children with DC in NK cells experienced a graft rejection. These observations suggest that, in the presence of recipient T-cell chimaerism, the chimaerism status in NK-cells on day +28 might be able to identify patients at high risk for late graft rejection.
Asunto(s)
Células Asesinas Naturales/inmunología , Trasplante de Células Madre , Linfocitos T/inmunología , Quimera por Trasplante , Adolescente , Niño , Preescolar , Familia , Femenino , Humanos , Inmunosupresores/clasificación , Inmunosupresores/uso terapéutico , Lactante , Masculino , Estudios Retrospectivos , Hermanos , Donantes de Tejidos , Acondicionamiento Pretrasplante/métodosAsunto(s)
Trasplante de Médula Ósea , ADN/metabolismo , Electroforesis Capilar/métodos , Repeticiones de Minisatélite , Reacción en Cadena de la Polimerasa , Quimera por Trasplante/genética , Alelos , Austria , Médula Ósea/patología , ADN/sangre , Cartilla de ADN/química , Electroforesis Capilar/economía , Estudios de Evaluación como Asunto , Fluorescencia , Humanos , Uñas/patología , Reacción en Cadena de la Polimerasa/economía , Polimorfismo Genético/genética , Sensibilidad y Especificidad , Factores de TiempoAsunto(s)
Trasplante de Células Madre Hematopoyéticas , Leucemia/diagnóstico , Leucemia/patología , Leucocitos/citología , Quimera por Trasplante , Adolescente , Niño , Preescolar , Femenino , Humanos , Inmunofenotipificación , Lactante , Leucemia/inmunología , Leucemia/terapia , Masculino , Reacción en Cadena de la Polimerasa , RecurrenciaRESUMEN
Sequential analysis of chimerism after allogeneic blood stem cell transplantation (BSCT) has been shown to be predictive for graft failure and relapse. We have explored the impact of a novel approach for the quantitative determination of chimerism using a commercial PCR assay with multiplex amplification of nine STR-loci and fluorescence detection. The feasibility was studied in 121 patients transplanted from related or unrelated donors. Follow-up investigation was performed in 88 patients. Twenty-eight of these patients had received a transplantation after dose-reduced conditioning therapy. Results were compared to data obtained by FISH analysis in a subgroup of patients receiving grafts from sex-mismatched donors. The analysis was possible in all patients, the median number of informative alleles was 4 (range 1-8) compared to 7 (range 1-9) in the related and unrelated situation, respectively. A good correlation was seen in 84 samples from 14 patients analyzed in parallel with STR-PCR and FISH. Decreasing values of donor chimerism were detected prior to or concomitantly with the occurrence of graft failure and relapse of disease in all patients investigated prospectively. Using FACS-sorted material, eg peripheral blood CD34+ cells, the assay permitted the detection of residual recipient cells with high sensitivity (down to one CD34+ Kasumi cell in 40,000 normal WBC). Evaluation of the inter-laboratory reproducibility revealed that in 20 samples analyzed in three different centers, the median coefficient of variation was 2.1% (range 0.7-9.6%). Taken together, the results support the use of the test as a valuable tool in the follow-up of patients undergoing allogeneic BSCT. In cases lacking PCR-detectable disease-specific gene products, this assay may represent an alternative to recently established real-time PCR methods.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Neoplasia Residual/diagnóstico , Secuencias Repetidas en Tándem , Quimera por Trasplante , Adolescente , Adulto , Alelos , Secuencia de Bases , Cartilla de ADN , Femenino , Neoplasias Hematológicas/genética , Neoplasias Hematológicas/patología , Humanos , Hibridación Fluorescente in Situ , Pérdida de Heterocigocidad , Masculino , Persona de Mediana Edad , Neoplasia Residual/genética , Reacción en Cadena de la PolimerasaRESUMEN
The monitoring of chimerism by PCR has become a routine diagnostic approach in patients after allogeneic bone marrow or peripheral blood stem cell transplantation. Nevertheless, a temporal correlation between molecular and hematologic assessment of engraftment has not been clearly established. To address this issue, and to determine the potential clinical implications of early kinetics of mixed chimerism, we have investigated 66 allogeneic stem cell transplantations (SCTs) in 58 pediatric patients suffering from different types of leukemia (n = 44) or non-malignant hematologic disorders (n = 14) by close molecular monitoring during the first days and weeks after transplantation. Patient- and donor-derived hematopoiesis were assessed at 1- to 3-day intervals in peripheral blood samples by PCR analysis of highly polymorphic microsatellite loci (STR-PCR). Detection of an increasing, and ultimately dominant donor-specific allelic pattern, which we defined as molecular engraftment, preceded hematologic engraftment by a median of 7 days (range 1-17 days) in all patients investigated. PCR analyses during the first days after transplantation facilitated detection of molecular engraftment according to the above definition by day +14 (range day +2 to day +14), thus permitting prediction of successful engraftment (upper limit of the two-sided confidence interval po = 6%) while the peripheral leukocyte counts were mostly below 200/microl. In three cases, however, the criteria for molecular engraftment were not fulfilled by day +14. These patients also failed to show hematologic engraftment, and required a second transplantation. Close monitoring by STR-PCR showed that graft rejection and autologous recovery can occur early and with very rapid dynamics. Molecular analysis of specific leukocyte subsets isolated by flow-sorting enabled sensitive assessment of changes in the pattern of chimerism which had escaped detection in assays using whole white blood cell (WBC) samples. This approach facilitated the identification of expanding or decreasing recipient cells, and permitted early detection of impending rejection or relapse. Moreover, monitoring of the dynamics of chimerism allowed rapid assessment of the response to therapy. Our observations provide support for the concept of initiating genotype analyses early after SCT and monitoring at rather short intervals to permit timely evaluation of clinically relevant processes, and to provide a basis for early implementation of treatment.